,FLT3 internal tandem duplication and JAK2 V617F mutations in de novo acute myelogenous leukemia: relation with induction chemotherapy and overall survival
- Citation:
- Assem, M. M., M. M. Noshy, G. M. Elsayed, H. R. Nassar, G. Thabet, G. M. Sherif, and A. K. Ahmad, ",FLT3 internal tandem duplication and JAK2 V617F mutations in de novo acute myelogenous leukemia: relation with induction chemotherapy and overall survival", Life Science Journal 2012, vol. 9, 2012.